{"Enoyl-[acyl-carrier-protein] reductase [NADH]": 0, "5-hydroxytryptamine receptor 2B": 1, "Mineralocorticoid receptor": 2, "Aromatase": 3, "Melatonin receptor type 1C": 4, "Protein kinase C alpha type": 5, "Prostacyclin receptor": 6, "Hematopoietic prostaglandin D synthase": 7, "Cholinergic receptor nicotinic alpha 5 subunit": 8, "Aryl hydrocarbon receptor": 9, "Transmembrane and immunoglobulin domain-containing 3": 10, "Voltage-dependent L-type calcium channel subunit alpha-1C": 11, "Casein kinase II subunit alpha": 12, "Serine/threonine-protein kinase pim-3": 13, "Hypoxanthine phosphoribosyltransferase": 14, "Calcitonin gene-related peptide 1": 15, "Genome polyprotein": 16, "Nitric oxide synthase, brain [D597N,M336V]": 17, "Peroxisome proliferator-activated receptor gamma": 18, "Chymotrypsinogen A": 19, "1-deoxy-D-xylulose 5-phosphate reductoisomerase": 20, "Solute carrier organic anion transporter family member 2A1": 21, "Collagenase 3": 22, "Glutamate--tRNA ligase": 23, "Caspase-9": 24, "Cyclin-dependent kinase 9": 25, "Glycine amidinotransferase, mitochondrial": 26, "Metallo-beta-lactamase VIM-2": 27, "A disintegrin and metalloproteinase with thrombospondin motifs 4": 28, "Cannabinoid receptor 1": 29, "Putative farnesyl pyrophosphate synthase": 30, "Neuromedin-K receptor": 31, "Renin": 32, "Carbonic anhydrase 1": 33, "Metabotropic glutamate receptor 1": 34, "Gag-Pol polyprotein [484-582,I494L,I497V,V499I,D514N,E519D,R541K,D544E,Q553K,N572D,L573M]": 35, "Urease": 36, "Neuropeptide Y receptor type 2": 37, "DNA polymerase III subunit tau": 38, "Galanin receptor type 2": 39, "Melatonin receptor type 1B": 40, "Neuronal acetylcholine receptor subunit alpha-3": 41, "Alpha-bungarotoxin": 42, "Protease": 43, "Cholecystokinin receptor type A": 44, "Serotonin N-acetyltransferase": 45, "Leukotriene B4 receptor 1": 46, "Hemagglutinin": 47, "Complex of Baculoviral IAP repeat-containing protein 7 [63-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]": 48, "Procathepsin L": 49, "Melatonin receptor type 1A": 50, "Mitogen-activated protein kinase 8": 51, "Adenosine receptor A2a": 52, "Mitogen-activated protein kinase 10": 53, "Farnesyl pyrophosphate synthase": 54, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q]": 55, "72 kDa type IV collagenase": 56, "Cholecystokinin": 57, "Protein arginine N-methyltransferase 3 [N508S]": 58, "Polycystin-1": 59, "C-C chemokine receptor type 1": 60, "Ionotropic glutamate receptor subunit Delta2": 61, "Vitamin K epoxide reductase complex subunit 1": 62, "Thymidine phosphorylase": 63, "Matrix metalloproteinase-14": 64, "Neuronal acetylcholine receptor subunit alpha-9": 65, "Sphingosine 1-phosphate receptor 5": 66, "Angiotensin-converting enzyme 2": 67, "Neuronal acetylcholine receptor subunit alpha-2": 68, "Corticotropin-releasing factor receptor 2": 69, "Tyrosine-protein kinase ABL1": 70, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T180C]": 71, "Carbonic anhydrase 3": 72, "Nitric oxide synthase, endothelial": 73, "Glutamate receptor ionotropic, kainate 4": 74, "Protachykinin-1": 75, "Calcitonin gene-related peptide type 1 receptor": 76, "Orexin receptor type 2": 77, "Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial": 78, "Tyrosine-protein kinase BTK": 79, "Gamma-aminobutyric acid receptor subunit alpha-3": 80, "Alpha-1D adrenergic receptor": 81, "Leucine-rich repeat serine/threonine-protein kinase 2": 82, "Cathepsin L2": 83, "Oxysterols receptor LXR-beta": 84, "Coagulation factor IX": 85, "Dimer of Gag-Pol polyprotein [491-589,Q498K,D521N,V555I,N579D]": 86, "Serine/threonine-protein kinase pim-1": 87, "Alpha-mannosidase 2": 88, "Collagenase ColG": 89, "Histone deacetylase 2": 90, "Glutamate receptor 2": 91, "cAMP-dependent protein kinase": 92, "Bromodomain-containing protein 4 [352-457]": 93, "Neuromedin-B receptor": 94, "Dihydrolipoyl dehydrogenase": 95, "Prostaglandin E2 receptor EP2 subtype": 96, "Bifunctional ligase/repressor BirA": 97, "Vasoactive intestinal polypeptide receptor 2": 98, "Endothelin-converting enzyme 1": 99, "Urotensin-2 receptor": 100, "Fatty acid-binding protein, liver": 101, "Carboxypeptidase B": 102, "Stromelysin-1": 103, "Sodium-dependent serotonin transporter": 104, "Pyroglutamylated RF-amide peptide receptor": 105, "Coagulation factor X": 106, "Glucocorticoid receptor": 107, "Oxa40": 108, "Thioredoxin reductase": 109, "Phosphoenolpyruvate carboxykinase, cytosolic [GTP]": 110, "5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase": 111, "Disintegrin and metalloproteinase domain-containing protein 17 [215-477,S266A,N452Q]": 112, "Glycogen phosphorylase, muscle form": 113, "Glutamate receptor ionotropic, kainate 5": 114, "DNA ligase 1": 115, "Delta-aminolevulinic acid dehydratase": 116, "Hypoxanthine-guanine-xanthine phosphoribosyltransferase": 117, "NAD kinase 1": 118, "Tyrosine-protein phosphatase non-receptor type 11": 119, "Tryptase beta-2": 120, "Kinesin-like protein KIF11": 121, "Deoxyuridine 5'-triphosphate nucleotidohydrolase": 122, "Beta-arrestin-2": 123, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T553C]": 124, "Orotidine-5'-phosphate decarboxylase": 125, "Suppressor of tumorigenicity 14 protein": 126, "Fatty-acid amide hydrolase 1": 127, "Metabotropic glutamate receptor 4": 128, "Lysosomal acid glucosylceramidase": 129, "DNA polymerase III subunit alpha": 130, "Vasopressin V2 receptor": 131, "Vitamin K-dependent protein C": 132, "Oxytocin receptor": 133, "Oxoeicosanoid receptor 1": 134, "Dimer of Gag-Pol polyprotein [514-612]": 135, "Muscarinic acetylcholine receptor M2": 136, "Caspase-8": 137, "S-methyl-5'-thioinosine phosphorylase": 138, "Myeloperoxidase": 139, "5-hydroxytryptamine receptor 1F": 140, "Cell division cycle 7-related protein kinase": 141, "Metabotropic glutamate receptor 3": 142, "Beta-galactosidase [V151I,I185V]": 143, "ALK tyrosine kinase receptor": 144, "Gamma-aminobutyric acid receptor subunit alpha-5": 145, "Ribosomal protein S6 kinase alpha-1": 146, "Kininogen-1": 147, "Dopamine receptor D4": 148, "Cyclin-dependent kinase 5": 149, "Complex of Sliding-clamp-loader large subunit [R175K] and Sliding-clamp-loader small subunit": 150, "Protein-glutamine gamma-glutamyltransferase 2": 151, "Peroxisome proliferator-activated receptor delta": 152, "Beta-mannosidase": 153, "5-hydroxytryptamine receptor 7": 154, "Carboxylic ester hydrolase": 155, "5-hydroxytryptamine receptor 1B": 156, "Heat shock protein HSP 90-alpha": 157, "Aminopeptidase N": 158, "Uridine 5'-monophosphate synthase": 159, "Aurora kinase A": 160, "Bile salt export pump": 161, "Papain": 162, "Aldo-keto reductase family 1 member C3": 163, "Amine oxidase [flavin-containing] A": 164, "Catenin beta-1 [138-686]": 165, "Beta-secretase 1": 166, "Corticotropin-releasing factor receptor 1": 167, "D(1A) dopamine receptor": 168, "Isoform GlyT-1A of Sodium- and chloride-dependent glycine transporter 1 (GlyT-1A)": 169, "Peroxisome proliferator-activated receptor alpha": 170, "Methionine aminopeptidase 2": 171, "Histamine H2 receptor": 172, "Solute carrier organic anion transporter family member [3-691]": 173, "Hepatocyte growth factor receptor": 174, "Sigma non-opioid intracellular receptor 1": 175, "Polyphenol oxidase 2": 176, "Prolyl 4-hydroxylase subunit alpha-1": 177, "Neuropeptide Y receptor type 4": 178, "Neurotensin": 179, "UDP-3-O-acyl-N-acetylglucosamine deacetylase": 180, "Beta-1 adrenergic receptor": 181, "Carbonic anhydrase 2": 182, "Pancreatic alpha-amylase": 183, "Thyrotropin-releasing hormone receptor": 184, "Inosine-5'-monophosphate dehydrogenase 1": 185, "Amyloid-beta precursor protein": 186, "Alpha-1A adrenergic receptor": 187, "Nociceptin receptor": 188, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,R176C]": 189, "Nicotinic acetylcholine receptor": 190, "Serine/threonine-protein kinase PAK 4": 191, "11-beta-hydroxysteroid dehydrogenase 1": 192, "D1 dopamine receptor": 193, "Pro-FMRFamide-related neuropeptide FF": 194, "Glucagon receptor": 195, "Substance-P receptor": 196, "neuronal acetylcholine receptor subunit alpha-4": 197, "Replicase polyprotein 1ab": 198, "Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1": 199, "Isochorismatase domain-containing protein": 200, "Estrogen receptor beta": 201, "B1 bradykinin receptor": 202, "Gag-Pol polyprotein [484-582,I497V,V499I,E519D,G532V,I538V,R541K,D544E,Q553K,V566A,L573M]": 203, "Neuraminidase": 204, "Calcium-activated potassium channel subunit beta": 205, "Serine/threonine-protein kinase pim-2": 206, "Translocator protein": 207, "Urokinase-type plasminogen activator": 208, "Baculoviral IAP repeat-containing protein 3": 209, "Trace amine-associated receptor 7b": 210, "Alpha-2A adrenergic receptor": 211, "Muscarinic acetylcholine receptor M1": 212, "Vasopressin V1b receptor": 213, "Glutamate receptor": 214, "Carbonic anhydrase 13": 215, "ATP receptor": 216, "D(1B) dopamine receptor": 217, "Casein kinase I isoform delta": 218, "cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A": 219, "Trifunctional purine biosynthetic protein adenosine-3": 220, "Dipeptidase 1": 221, "D(3) dopamine receptor": 222, "Histidinol dehydrogenase, chloroplastic": 223, "Bromodomain-containing protein 4 [57-168]": 224, "CARBONIC ANHYDRASE": 225, "cAMP-specific 3',5'-cyclic phosphodiesterase 4B": 226, "Rat vasopressin-neurophysin": 227, "Vitamin K epoxide reductase complex subunit 1-like protein 1": 228, "1-aminocyclopropane-1-carboxylate oxidase 1": 229, "Plasmepsin II": 230, "Alpha-2B adrenergic receptor": 231, "Carbonic anhydrase 4": 232, "Transporter": 233, "Orotate phosphoribosyltransferase": 234, "Acetylcholine-binding protein": 235, "Carbonic anhydrase 12": 236, "Diacylglycerol O-acyltransferase 1": 237, "Cathepsin H": 238, "Adenosine deaminase": 239, "Melanocortin receptor 5": 240, "Prostaglandin E2 receptor EP1 subtype": 241, "P2Y purinoceptor 2": 242, "Plasmepsin IV": 243, "Mitogen-activated protein kinase 1": 244, "Glutamate receptor ionotropic, kainate 2": 245, "Vascular endothelial growth factor receptor 2": 246, "Ketol-acid reductoisomerase (NADP(+))": 247, "Adenosine receptor A2": 248, "Pepsin A": 249, "Cytochrome P450 3A4": 250, "E3 ubiquitin-protein ligase XIAP [241-356]": 251, "P2X purinoceptor 1": 252, "HIV-1 protease": 253, "Serine/threonine-protein kinase mTOR": 254, "Chymotrypsin-C": 255, "Proto-oncogene tyrosine-protein kinase Src": 256, "Histone-lysine N-methyltransferase, H3 lysine-79 specific": 257, "Progesterone receptor": 258, "Tyrosine-protein kinase Lck": 259, "Cathepsin B": 260, "Cathepsin S": 261, "Glutamine--tRNA ligase": 262, "Beta-carbonic anhydrase 1": 263, "Glutaminyl-peptide cyclotransferase-like protein": 264, "Androgen receptor": 265, "Histone deacetylase 3": 266, "Neutrophil elastase": 267, "Melatonin receptor": 268, "Glycine receptor subunit alpha-1": 269, "Prostaglandin F2-alpha receptor": 270, "Prostaglandin E2 receptor EP4 subtype": 271, "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform": 272, "ATP synthase subunit a": 273, "Lysine-specific demethylase 5A": 274, "5-hydroxytryptamine receptor 2A": 275, "Serine protease 1": 276, "Voltage-dependent T-type calcium channel subunit alpha-1H": 277, "Tissue-type plasminogen activator": 278, "Indoleamine 2,3-dioxygenase 1": 279, "Dimer of Growth hormone secretagogue receptor type 1": 280, "Glycine--tRNA ligase": 281, "Thymidylate synthase": 282, "Pyrazinamidase/nicotinamidase PncA": 283, "Acetylcholinesterase": 284, "Dihydrofolate reductase": 285, "Homoisocitrate dehydrogenase, mitochondrial": 286, "Substance-K receptor": 287, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A]": 288, "Alpha-2C adrenergic receptor": 289, "5-hydroxytryptamine receptor 6": 290, "Histamine H4 receptor": 291, "Bcl-2-like protein 1": 292, "Matrilysin": 293, "N-formyl peptide receptor 2": 294, "Histamine receptor H4": 295, "Mitogen-activated protein kinase 9": 296, "Prothrombin": 297, "Neprilysin": 298, "Caspase-2": 299, "Dimer of Gag-Pol polyprotein [489-587]": 300, "L-lactate dehydrogenase": 301, "Enteropeptidase": 302, "Bifunctional purine biosynthesis protein ATIC": 303, "A disintegrin and metalloproteinase with thrombospondin motifs 5": 304, "Carbonic anhydrase 15 [19-324]": 305, "Dimer of Gag-Pol polyprotein [491-589,Q7K,L33I,C67B,C95B]": 306, "Dipeptidyl peptidase 9": 307, "Plasma kallikrein": 308, "Complex of Baculoviral IAP repeat-containing protein 7 [1-159,S150G] and E3 ubiquitin-protein ligase XIAP [336-348]": 309, "25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial": 310, "Protein O-GlcNAcase": 311, "Muscarinic acetylcholine receptor M5": 312, "Promotilin": 313, "Protein kinase C beta type": 314, "Beta-hexosaminidase subunit beta": 315, "Muscarinic acetylcholine receptor M3": 316, "2,6-dichloro-p-hydroquinone 1,2-dioxygenase": 317, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,F550C]": 318, "Vitamin D3 receptor": 319, "Leukotriene B4 receptor 2": 320, "Gastrin-releasing peptide receptor": 321, "Metabotropic glutamate receptor 8": 322, "Adenosine receptor A3": 323, "Gag-Pol polyprotein [484-582,I497V,V499I,E519D,R541K,D544E,Q553K,A555V,G557S,I568V,L574M,L573M]": 324, "Signal transducer and activator of transcription 5B": 325, "Transient receptor potential cation channel subfamily V member 1": 326, "Vasoactive intestinal polypeptide receptor 1": 327, "Glutamate receptor 3": 328, "Fatty-acid amide hydrolase 1 [30-579]": 329, "Polyphenol oxidase 1 [N65D,S176D,K211T,P277A,P406L]": 330, "Serine/threonine-protein kinase Chk1": 331, "Somatostatin receptor type 3": 332, "Sphingosine 1-phosphate receptor 4": 333, "Carboxypeptidase B2": 334, "Alpha-2A adrenergic receptor [16-465]": 335, "Tubulin--tyrosine ligase": 336, "Caspase-1": 337, "Prostaglandin D2 receptor 2": 338, "Vasopressin V1a receptor": 339, "Sphingosine 1-phosphate receptor 3": 340, "Heat shock 70 kDa protein 1A": 341, "Bifunctional dihydrofolate reductase-thymidylate synthase": 342, "Lysine-specific histone demethylase 1A": 343, "Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]": 344, "Beta-secretase 2": 345, "Baculoviral IAP repeat-containing protein 2 [253-363]": 346, "Muscarinic acetylcholine receptor": 347, "Aldo-keto reductase family 1 member B1 [W220Y,C299A]": 348, "Aldo-keto reductase family 1 member B1 [C299A]": 349, "5-hydroxytryptamine 1D receptor": 350, "Endothelin-1 receptor": 351, "Beta-arrestin-1": 352, "Prostaglandin-H2 D-isomerase": 353, "Nitric oxide synthase, brain [D597N]": 354, "Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI": 355, "Gamma-hydroxybutyrate receptor": 356, "Equilibrative nucleoside transporter 1": 357, "Tyrosine-protein kinase JAK2": 358, "Coagulation factor XI": 359, "Mu-type opioid receptor": 360, "Glutamine synthetase": 361, "Coagulation factor VII": 362, "Adenosine receptor A1": 363, "Capsid scaffolding protein": 364, "Histone deacetylase 1": 365, "Nicotinamidase": 366, "Alpha-methylacyl-CoA racemase": 367, "N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase": 368, "Aurora kinase B": 369, "Tyrosine-protein kinase JAK3": 370, "C-C chemokine receptor type 3": 371, "Baculoviral IAP repeat-containing protein 2 [269-336]": 372, "Neuropeptide Y receptor type 5": 373, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,D531N]": 374, "Pro-glucagon": 375, "VIP peptides": 376, "UDP-galactopyranose mutase": 377, "Neuronal acetylcholine receptor subunit alpha-6": 378, "Opioid growth factor receptor-like protein 1": 379, "5-hydroxytryptamine receptor 1D": 380, "Orotidine 5'-phosphate decarboxylase": 381, "Chymase": 382, "Cyclin-dependent kinase 7": 383, "Melanocortin receptor 3": 384, "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform": 385, "Beta-glucuronidase": 386, "Peptidyl-prolyl cis-trans isomerase FKBP1A": 387, "Serum paraoxonase/arylesterase 1": 388, "Sphingosine 1-phosphate receptor 2": 389, "P2X purinoceptor 2": 390, "Plasmepsin I": 391, "Mitogen-activated protein kinase kinase kinase 14": 392, "Peptide deformylase": 393, "Dipeptidyl peptidase 1": 394, "Plasminogen": 395, "Cholinergic receptor, nicotinic alpha 1": 396, "Trace amine-associated receptor 1": 397, "G_PROTEIN_RECEP_F1_2 domain-containing protein": 398, "Baculoviral IAP repeat-containing protein 3 [238-349]": 399, "Xanthine-guanine phosphoribosyltransferase": 400, "Bis(5'-adenosyl)-triphosphatase": 401, "Homoisocitrate dehydrogenase": 402, "Somatostatin receptor type 5": 403, "Beta-lactamase": 404, "Dimer of Gag-Pol polyprotein [491-589,Q498K,L501I,V555I,A562V,G564S,I575V,L581M]": 405, "Caspase-5": 406, "Thromboxane A2 receptor": 407, "Aspartate--tRNA ligase": 408, "Metabotropic glutamate receptor 6": 409, "EEF1AKMT4-ECE2 readthrough transcript protein": 410, "Neuropeptide FF receptor 2": 411, "NAD kinase": 412, "Dimer of Gag-Pol polyprotein [491-589,Q496K]": 413, "Prostaglandin E2 receptor EP3 subtype": 414, "N(G),N(G)-dimethylarginine dimethylaminohydrolase 1": 415, "Receptor activity-modifying protein 1": 416, "VIM-24": 417, "Neuropeptide Y receptor type 1": 418, "Leukotriene A-4 hydrolase": 419, "Carbonic anhydrase 14": 420, "Angiotensin-converting enzyme": 421, "Glycogen synthase kinase-3 beta": 422, "Melanocyte-stimulating hormone receptor": 423, "Dimer of Gag-Pol polyprotein [489-587,M535I,L552P,A560V,V571F,I573V]": 424, "Soluble acetylcholine receptor": 425, "Dimer of Gag-Pol polyprotein [489-587,V571A]": 426, "Epidermal growth factor receptor": 427, "Glutamate receptor ionotropic, NMDA 2B": 428, "Gag-Pol polyprotein [489-587,G537V,H558K,V571A]": 429, "Isoform Alpha-4-2 of Neuronal acetylcholine receptor subunit alpha-4 (Alpha-4-2)": 430, "Signal transducer and activator of transcription 3 [127-722]": 431, "Carboxypeptidase A1": 432, "Mast/stem cell growth factor receptor Kit": 433, "Hrh3 protein": 434, "Trans-sialidase": 435, "Prostaglandin G/H synthase 2": 436, "Bombesin": 437, "Protein kinase C delta type": 438, "Cyclin-dependent kinase 4": 439, "Prephenate dehydrogenase": 440, "Caspase-7": 441, "Dimer of Gag-Pol polyprotein [489-587,L499I,L508Q,K509R,E524D,M525I,S526N,M535I,I539V,I543V,I551V,L552P,A560V,V571A,L579M]": 442, "Somatostatin receptor type 2": 443, "Metabotropic glutamate receptor 7": 444, "Porphobilinogen deaminase": 445, "Signal transducer and activator of transcription 5A": 446, "Opioid receptor delta 1": 447, "Kappa-type opioid receptor": 448, "Orexin/Hypocretin receptor type 1": 449, "Metabotropic glutamate receptor 2": 450, "Amine oxidase": 451, "Carbonic anhydrase 5B, mitochondrial": 452, "dCTP pyrophosphatase 1": 453, "Neuronal acetylcholine receptor subunit alpha-4": 454, "Baculoviral IAP repeat-containing protein 3 [252-340]": 455, "Baculoviral IAP repeat-containing protein 2 [266-354]": 456, "Peptidoglycan-N-acetylglucosamine deacetylase": 457, "S-adenosylmethionine synthase isoform type-2": 458, "Complement C1r subcomponent": 459, "Melanin-concentrating hormone receptor 1": 460, "Bombesin receptor subtype-3": 461, "Isoleucine--tRNA ligase": 462, "GABA(A) receptor-associated protein": 463, "Urokinase plasminogen activator surface receptor": 464, "Platelet-activating factor receptor": 465, "Cathepsin D": 466, "Carbonic anhydrase 9": 467, "Beta-galactosidase": 468, "Matrix metalloproteinase-9": 469, "Poly [ADP-ribose] polymerase 1": 470, "Gamma-aminobutyric acid type B receptor subunit 1": 471, "cholinergic receptor, nicotinic, alpha 1 (Muscle) isoform X1": 472, "Carbonic anhydrase 6": 473, "Matrix metalloproteinase-14 [1-20,P8S]": 474, "Inosine-5'-monophosphate dehydrogenase 2": 475, "Macrophage metalloelastase": 476, "Protein arginine N-methyltransferase 1 [11-371]": 477, "Uncharacterized protein": 478, "Transcription initiation factor IIA subunit 1": 479, "cAMP-specific 3',5'-cyclic phosphodiesterase 4D": 480, "P2X purinoceptor 3": 481, "Cytochrome P450 11B2, mitochondrial": 482, "Queuine tRNA-ribosyltransferase": 483, "Phenylethanolamine N-methyltransferase": 484, "Pro-thyrotropin-releasing hormone-B": 485, "cGMP-dependent protein kinase 1": 486, "Dual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A": 487, "Nitric oxide synthase, brain": 488, "Non-receptor tyrosine-protein kinase TYK2": 489, "Pro-neuropeptide Y": 490, "Isochorismatase family protein": 491, "DNA-(apurinic or apyrimidinic site) endonuclease": 492, "Bifunctional dihydrofolate reductase-thymidylate synthase [1-238,S58R,S117N]": 493, "Coagulation factor XII": 494, "cAMP-specific 3',5'-cyclic phosphodiesterase 4A": 495, "Pancreatic polypeptide receptor 1": 496, "Melanin-concentrating hormone receptor 2": 497, "1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial": 498, "Glutathione-disulfide reductase": 499, "Sodium-dependent dopamine transporter": 500, "Prostaglandin G/H synthase 1": 501, "Potassium voltage-gated channel subfamily H member 2": 502, "Homeobox C9": 503, "Sodium-dependent noradrenaline transporter": 504, "Tumor necrosis factor": 505, "Glutamate receptor ionotropic, kainate 1": 506, "Genome polyprotein [1027-1206,R1052K]": 507, "Lethal factor": 508, "C-C chemokine receptor type 2": 509, "Dipeptidyl peptidase 4": 510, "Rho-associated protein kinase 2": 511, "Muscarinic acetylcholine receptor M3 [1-273,470-589,N6Q,N15Q,N41Q,N48Q,N52Q,T556C]": 512, "Purine nucleoside phosphorylase": 513, "Cyclin-dependent kinase 2": 514, "Serine/threonine-protein kinase ATR": 515, "Neutrophil collagenase": 516, "Arachidonate 5-lipoxygenase-activating protein": 517, "Gag-Pol polyprotein": 518, "Isoform PNNOS of Nitric oxide synthase, brain (PNNOS) -973,I269V,M336V,D597N]": 519, "Beta-3 adrenergic receptor": 520, "Protein arginine N-methyltransferase 6": 521, "Dimer of Gag-Pol polyprotein [489-587,I539V]": 522, "Beta-secretase 1 [22-454]": 523, "Histamine receptor H3": 524, "Nicotinate-nucleotide adenylyltransferase": 525, "Muscarinic acetylcholine receptor M4": 526, "Protein arginine N-methyltransferase 8": 527, "Glutamate metabotropic receptor 1": 528, "Dimer of Gag-Pol polyprotein [501-599]": 529, "Urokinase-type plasminogen activator [179-431,I214M,N322A,S371A]": 530, "Gag-Pol polyprotein [484-582,Q491K,I494L,I497V,V499I,E519D,R541K,D544E,Q553K,L573M]": 531, "Liver carboxylesterase 1": 532, "Sodium- and chloride-dependent glycine transporter 1": 533, "Cysteinyl leukotriene receptor 1": 534, "Lysosomal Pro-X carboxypeptidase": 535, "Carbonic anhydrase": 536, "Mitogen-activated protein kinase 14": 537, "Type-1 angiotensin II receptor A": 538, "Histamine H3 receptor": 539, "Beta-lactamase CTX-M-1": 540, "Glutaminyl-peptide cyclotransferase": 541, "Glycylpeptide N-tetradecanoyltransferase": 542, "Monocarboxylate transporter 1": 543, "Prostaglandin D2 receptor": 544, "Alpha-synuclein": 545, "Calcium release-activated calcium channel protein 1": 546, "Excitatory amino acid transporter 2": 547, "Gamma-aminobutyric acid receptor subunit alpha-4": 548, "Alpha-glucosidase MAL12": 549, "5-hydroxytryptamine receptor 1E": 550, "Baculoviral IAP repeat-containing protein 3 [255-322]": 551, "P2X purinoceptor 7": 552, "Oxysterols receptor LXR-alpha": 553, "Caspase-3": 554, "D(4) dopamine receptor": 555, "Gastrin-releasing peptide": 556, "Kinesin-like protein KIF11 [A356T]": 557, "fMet-Leu-Phe receptor": 558, "Cytochrome P450 2A6": 559, "RAC-alpha serine/threonine-protein kinase [139-480,S378A,S381A,T450D,S473D]": 560, "Calpain-1 catalytic subunit": 561, "Caspase-4": 562, "Angiogenin": 563, "Glutamate metabotropic receptor 5": 564, "Carbonic anhydrase 5A, mitochondrial": 565, "Hypoxanthine-guanine phosphoribosyltransferase": 566, "Cathepsin L": 567, "Gastrin/cholecystokinin type B receptor": 568, "5-hydroxytryptamine receptor 3A": 569, "Gamma-aminobutyric acid receptor subunit alpha-6": 570, "Isoform PDE10A2 of cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (PDE10A2)": 571, "Complement C1s subcomponent": 572, "Carbamoyl-phosphate synthase small chain": 573, "Progonadoliberin-1": 574, "Lipoxygenase": 575, "Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase": 576, "Thymidine kinase": 577, "Galanin receptor type 1": 578, "Solute carrier family 22 member 1": 579, "Rho-associated protein kinase 1 [17-535]": 580, "Pyrazinamidase/nicotinamidase, PncA protein": 581, "Sphingosine 1-phosphate receptor 1": 582, "Isoform 1 of Metabotropic glutamate receptor 5 (5a)": 583, "Caspase-6": 584, "Amine oxidase [flavin-containing] B": 585, "cGMP-dependent 3',5'-cyclic phosphodiesterase": 586, "Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,R541K,D544E,L547P,Q553K,A555V,G557S,I568V,L573M,L574M]": 587, "Bacterial leucyl aminopeptidase": 588, "Complex of Sliding-clamp-loader large subunit [R175L] and Sliding-clamp-loader small subunit": 589, "Probable nicotinate-nucleotide adenylyltransferase": 590, "Rho-associated protein kinase 2 [11-552]": 591, "Prokineticin receptor 1": 592, "Serine/threonine-protein kinase PLK1": 593, "Stromelysin-2": 594, "Cyclin-dependent kinase 1": 595, "C-C chemokine receptor type 5": 596, "5-hydroxytryptamine receptor 5A": 597, "Nischarin": 598, "Galanin receptor type 3": 599, "Norepinephrine transporter": 600, "Acetylcholine receptor subunit alpha": 601, "5-hydroxytryptamine receptor 2C": 602, "Beta-2 adrenergic receptor": 603, "Ribosomal protein S6 kinase alpha-6": 604, "Cholinergic receptor nicotinic alpha 6 subunit": 605, "Somatostatin receptor type 1": 606, "Gag-Pol polyprotein [484-582,I494L,I497V,V499I,E519D,I534V,R541K,D544E,Q553K,A555V,L573M]": 607, "Gamma-aminobutyric acid receptor subunit alpha-2": 608, "3-oxoacyl-[acyl-carrier-protein] synthase 1": 609, "Somatostatin receptor type 4": 610, "Sodium channel protein type 9 subunit alpha": 611, "Interstitial collagenase": 612, "Uracil-DNA glycosylase": 613, "Alpha-1B adrenergic receptor": 614, "5-hydroxytryptamine receptor 1A": 615, "Endothelin receptor type B": 616, "Glutamate receptor ionotropic, NMDA 1": 617, "Proteinase-activated receptor 2": 618, "Adenosine receptor A3 [I248L]": 619, "D(2) dopamine receptor": 620, "Dihydroorotate dehydrogenase (quinone), mitochondrial": 621, "Melanocortin receptor 4": 622, "Delta-type opioid receptor": 623, "Glutamine--fructose-6-phosphate aminotransferase [isomerizing]": 624, "Aldehyde oxidase 1": 625, "Nitric oxide synthase, inducible": 626, "Tyrosine-protein kinase JAK1": 627, "Alpha-carbonic anhydrase domain-containing protein": 628, "Peptidyl-prolyl cis-trans isomerase A": 629, "P2X purinoceptor 4": 630, "Sodium channel protein type 10 subunit alpha": 631, "kappa-type opioid receptor isoform 1": 632, "Adenosine receptor A2b": 633, "Cholinesterase": 634, "Oxaloacetate decarboxylase": 635, "Thromboxane-A synthase": 636, "Adenylate cyclase type 2": 637, "Gag-Pol polyprotein [484-582,Q491K,I497V,V499I,E519D,G532V,I538V,R541K,D544E,L547P,Q553K,V566A,L573M]": 638, "Dipeptidyl peptidase 8": 639, "Cathepsin K": 640, "Prolactin-releasing peptide receptor": 641, "Metabotropic glutamate receptor 5": 642, "Dimer of Gag-Pol polyprotein [491-589,Q498K,L501I,G539V,I545V,V555I,V573A]": 643, "Gamma-aminobutyric acid receptor subunit alpha-1": 644, "Pituitary adenylate cyclase-activating polypeptide": 645, "GLRA1 protein": 646, "neuronal acetylcholine receptor subunit alpha-2": 647, "Tyrosine-protein phosphatase non-receptor type 1 [1-298]": 648, "Type-2 angiotensin II receptor": 649, "Tyrosine-protein phosphatase non-receptor type 1": 650, "5-hydroxytryptamine receptor 5B": 651, "Bifunctional aspartokinase/homoserine dehydrogenase 1": 652, "Carbonic anhydrase 7": 653, "Aldo-keto reductase family 1 member B1": 654, "Tyrosine-protein phosphatase non-receptor type 2": 655, "cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A": 656, "Histamine H1 receptor": 657, "E3 ubiquitin-protein ligase Mdm2": 658, "Cysteinyl leukotriene receptor 2": 659, "Prunasin hydrolase": 660, "Ribonuclease pancreatic": 661, "2'-deoxynucleoside 5'-phosphate N-hydrolase 1": 662, "Neuronal acetylcholine receptor subunit alpha-7": 663, "Prokineticin receptor 2": 664, "5-hydroxytryptamine receptor 4": 665, "TYR_PHOSPHATASE_2 domain-containing protein": 666, "Dimer of Gag-Pol polyprotein [501-599,Q508K,L534I,L564I,C568A,C596A,I551V]": 667, "Cannabinoid receptor 2": 668, "Apoptosis regulator Bcl-2": 669, "cGMP-inhibited 3',5'-cyclic phosphodiesterase 3B": 670, "Histone-arginine methyltransferase CARM1": 671, "Enoyl-[acyl-carrier-protein] reductase [NADH] [T276S]": 672, "3-dehydroquinate synthase": 673, "Tyrosine-protein kinase ITK/TSK": 674, "Estrogen receptor": 675}